Home | Contact Us | Search | Site Map
About Us Technology Products R&D Partners Investors Media Careers Hidden
Crucell
AdVac® Technology



  PER.C6® Technology
  Vaccine Technology
  PER.C6® Technology
  AdVac® Technology
  Description
  Applications
  Virosome Technology
  Recombinant Paramyxovirus
  Hansenula polymorpha
  Partnering Opportunities
  Protein Technology

Key Strengths
  • Vectors used with AdVac® technology share the advantages of the commonly used adenoviral vectors such as: scalable RCA-free production, high yields and the ability to mediate a strong T-cell immune response. 

 

  • The AdVac® technology, in contrast to commonly used adenoviral vectors, can circumvent pre-existing immunity offering accurate dose control of the vaccines based on this technology. 

  • AdVac® vectors can be engineered to contain small genetic fragments of different viruses, parasites and bacteria. This makes the development of a wide variety of novel vaccines against a broad range of dangerous human pathogens possible. 

 

  • AdVac® vectors can be produced on the PER.C6® cell line, which supports the cost-effective production of safe vaccines in industrial-scale quantities for vaccines for both the developed and non-developed world.

 
  E-mail this page   Print this page

    Home  |  Contact Us  |  Search  |  Site Map  |  
MoveNext - Latus © Crucell 2006 | Disclaimer